Engineering aortic valves via transdifferentiating fibroblasts into valvular endothelial cells without using viruses or iPS cells.
Tang P, Wei F, Qiao W, Chen X, Ji C, Yang W, Zhang X, Chen S, Wu Y, Jiang M, Ma C, Shen W, Dong Q, Cao H, Xie M, Cai Z, Xu L, Shi J, Dong N, Chen J, Wang N.
Tang P, et al. Among authors: ma c.
Bioact Mater. 2024 Nov 23;45:181-200. doi: 10.1016/j.bioactmat.2024.11.018. eCollection 2025 Mar.
Bioact Mater. 2024.
PMID: 39651397
Free PMC article.